In the latest trading session, Moderna (MRNA) closed at $101.11, marking a -0.79% move from the previous day.

1 Stock Down 43% to Buy and Hold for 10 Years

08:53am, Sunday, 21'st Jan 2024
Moderna's revenue and earnings dropped off a cliff last year. However, the biotech is close to launching a new product.

Better Bull Market Buy: Pfizer vs. Moderna

06:49am, Saturday, 20'th Jan 2024
Pfizer is completing its biggest string of product launches ever, which should spur a new era of growth. Moderna expects to soon have a new RSV vaccine on the market, with other products to follow.
Moderna went from being a stock market winner, soaring more than 400%, to a losing stock in recent times. Investors have worried about coronavirus vaccine declines and the biotech company's future rev
Moderna (MRNA) closed at $100.35 in the latest trading session, marking a -1.77% move from the prior day.
With so many question marks facing the viability of the equities sector, concerned investors may want to turn their attention to compelling healthcare stocks. Primarily, the sector benefits from perma
Plug Power's financials are in horrible shape, and a lack of cash is a big concern for investors. Moderna's reliance on COVID and flu revenue could limit any growth it's able to generate ahead.
While the technology sector – especially regarding artificial intelligence – may have captured the spotlight, investors ought to consider adding healthcare stocks to their portfolio. If I had to b
Owning powerhouse stocks can add significant value to your portfolio. Megatrends are those that are shaping or will shape society in significant ways.
The latest trading day saw Moderna (MRNA) settling at $109.46, representing a -0.65% change from its previous close.
Today, identifying investments with promising growth potential is a quest every investor undertakes. Within the loud noises of the stock market, three standout companies are making waves.
Moderna (MRNA) reports unaudited product sales of around $6.7 billion for 2023, meeting its previously issued guidance. Share price rises following the announcement.
The S&P 500 is within striking distance of entering official bull market territory. To qualify, the index would need to rise more than 20% from its previous low and hit a new all-time high.
Moderna, Inc. (MRNA) Presents at J.P. Morgan 42nd Annual Healthcare Conference Transcript
Metagenomi Technologies, a startup developing treatments for genetic diseases backed by Moderna Therapeutics Inc (NASDAQ:MRNA) and Bayer AG (ETR:BAYN, OTC:BAYZF), filed for a US IPO on Friday.  Foun
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE